ISBT 2022 Virtual Congress

Nafishah Ahmad

"Completed Post-Graduate Degree in Master of MEdicine (Transfusion Medicine) in 2011 Currently is the Head of Transfusion Medicine Department, Hospital Tengku Ampuan Rahimah (HTAR) Klang and State of Selangor Head of Transfusion Service since 02/01/2019 until present. Professional Experience Actively involved in Safe Transfusion Practice at Hospital and State levels Monitoring haemovigilance data and statistics at Hospital levels Monitoring customer satisfaction program in Transfusion Medicine, handling customer complaints and troubleshooting of problems. Involved in training nurses, house officers and Medical Laboratory Technicians (MLT) through CMEs and hands-on program held at Hospital and State levels Manage and verify reports for incidences such as transfusion reactions, donor adverse reactions, antibody cases and Cross-matching problems. Monitoring RCPA program for Immunohaematology Unit at the department "

---

Nor Hafizah Ahmad

Dr. Nor Hafizah Ahmad is a Transfusion Medicine Specialist who is currently the Head of Clinical Transfusion Division in National Blood Centre, Kuala Lumpur, Malaysia heading both National Immunohematology Reference Laboratory and Clinical Transfusion Section. She graduated from University Science Malaysia in year 2004 and completed her specialist training in M.Med Transfusion Medicine in year 2013 from Advanced Medical Dental Institute, USM. She has completed her subspecialty training in Patient Blood Management/Clinical Transfusion and Immunohematology in Sweden recently and has been regularly involved in conducting training around the country for many years in both areas. She has been appointed as the chairperson for National Rare Donor Program and is actively involved in the implementation of Patient Blood Management and Massive Transfusion Protocol in her place. She is involved as the secretariat for National Patient Blood Management Committee and also an active member of Malaysian Blood Society of Transfusion. She has also been invited as speaker in various conferences at local and national level in the field of Clinical Transfusion Immunohematology.

---

Nour Almozain

Nour Almozain is a hematopathologist and transfusion medicine physician from Saudi Arabia. She is a Transfusion Medicine fellow in the Royal College of Pathologist UK.

She is a member of the ISBT Clinical Transfusion Subgroup and an active member in the AABB. She has a special interest in patient blood management, hemovigilance and obstetric hematology.

: @@NourAlmozain

Abdulrahman Alshalani

Phd candidate at the University of Amsterdam

Irene Ayerra

Irene (25 years old) has a degree in Mathematics (with honours) and a Master's Degree in Data Science. She has been researching the application of mathematics to health in the area of Transfusion Medicine for two years.

Saeede Bagheri

Saeede bagheri, MSC of Haematology and Blood Banking, working as a Professor and Medical laboratory scientist.

Cathy Balding

Cathy works with acute, community and aged care boards, executives and leaders to make quality make sense; specialising in purposeful and strategic clinical governance systems that focus on achieving a consistently high quality point of care and service experience for staff and consumers. She is the author of three books on this topic and has conducted published research into characteristics of effective quality and clinical governance systems. Cathy has developed quality and clinical governance frameworks, and associated tools and training, for Departments of Health and many aged, community and healthcare services. She was a healthcare executive, policymaker and accreditation assessor for two decades before starting her consulting business 15 years ago. As QualityworksPL, Cathy provides a suite of quality and clinical governance tools and training via her website, including the No Harm Done podcast.

: https://www.cathybalding.com/
: cathybalding
: @CathyBalding

---

Behnaz Bayat

Academic Curriculum Vitae / Employment:

2010-2014: Postdoctoral fellow in immunohematology laboratory of the institute for clinical immunology and transfusion medicine, Justus Liebig University, Giessen, Germany

2014-Present: The Head of the Research Laboratory and diagnostic fellow at granulocyte and immunohematology laboratories of the institute for clinical immunology and transfusion medicine, Justus-Liebig-University Giessen, Germany

2015-Present: Teaching the immunology course for medical students, Justus-Liebig-University Giessen, Germany Functions in scientific societies and institutions: Chairperson of International Working Party on Granulocyte Immunobiology, International Society for Blood Transfusion (ISBT) Member of the German Society for Transfusion Medicine and Immunohematology Advisory Member, International Working Party on Granulocyte Immunobiology, International Society for Blood Transfusion (ISBT)

Work experience:

2010 - Present: Working as a research and diagnostic fellow at platelet and granulocyte immunohematology of Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig-University Giessen, Germany 2

015 Present: Teaching the immunology course for medical students, Justus-Liebig-University Giessen, Germany

2007 - 2010: Worked as Ph.D. student at Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig University Giessen, Germany

2005 - 2007: Medical genetic Lab leader at the Medical Department of National Institute for Genetic Engineering Biotechnology, Tehran, Iran

1999 - 2005: Research assistant at the Genetic Department National

: behnaz-bayat-a3658ab0

---

Renée Bazin

Renée Bazin obtained her PhD in biochemistry in 1988. She started her career as a research scientist at canadian red cross society and then became Director of Research when Héma-Québec was created in 1998. Renée is now Scientific Director, Medical Affairs and Innovation.

Throughout her career, she led several research projects including work on monoclonal antibodies and plasma immunoglobulins. more recently, she was responsible for the laboratory aspects of covid convalescent plasma program at Hema-Québec and was actively involved in collaborative projects on the humoral immunity against sars-cov-2, leading to the publication of 13 articles on this subject in the last 12 months.

Lilian Antwi Boateng

Dr. (Mrs.) Lilian Antwi Boateng is an early career lecturer and researcher in the haematology and immunohematology Unit of the Kwame Nkrumah University of Science and Technology, Ghana since 2012. she supervises and undertakes research specialising in blood transfusion and red blood cell antigens and alloantibodies Lilian holds a PhD in blood transfusion from the University of Liverpool. She holds Master and Bachelor of Science degrees in Biomedical Science from the University of Westminster, United Kingdom and Bachelor of Medical Laboratory Technology from Kwame Nkrumah University of Science and Technology, Ghana respectively. She also undertook a six months residency programme in blood banking at the University of Michigan and the University of Michigan blood bank reference laboratory as a fellow of the University of Michigan African Presidential Scholars Programme (UMAPS). Lilians aspiration in the long term is to progress professionally as a national and international transfusion research leader.

---

Darija Bogdanić

"Graduated from the university of zagreb, school of medicine. currently working as transfusion medicine resident at uhc zagreb. spoken languages: english, german, and a little swedish hobbies: reading, traveling, walking"

Bryan Brad

Dr brad bryan is the executive director of oklahoma blood institute's biolinked program, which provides blood centers a secure registry to recruit blood donors for clinical research opportunities. dr. bryan completed a fellowship at harvard medical school, a phd in medical sciences from texas a&m university and a mba from university of massachusetts-amherst. dr bryan has held executive leadership positions in various healthcare organizations and is an entrepreneur, having successfully founded several biomedical sciences companies. dr. bryan has also published over 60 peer reviewed research publications in the areas of cardiovascular biology and oncology, and obtained continuous grant funding while serving as a professor at texas tech university health sciences center.

Thierry Burnouf

Thierry Burnouf, PhD, is Distinguished Professor and Vice-Dean of the College of Biomedical Engineering, Taipei Medical University, Taiwan. He is also Director of the International PhD Program in Biomedical Engineering and Professor at the Graduate Institute of Biomedical Materials and Tissue Engineering. For ISBT, Thierry acts as the Treasurer of the Working Party on Cellular therapies (chair: Mickey Koh), the Secretary of the Working Party on Global Blood Safety (chair: Martin Smid), and as a member of the Working Group on COVID-19 Convalescent Plasma Working transfusion subgroup (chair: Arwa Al-Riyami). His current field of research interest focuses on bioengineering and bioprocessing of virally-safe human platelet growth factor preparations (human platelet lysates) and blood cell-derived extracellular vesicles for regenerative medicine, cell therapy, and drug delivery. Previously Dr Burnouf has been the Director of Research and Development and Production Director of the plasma fractionation center at the Regional Blood Transfusion Center (Lille, France) and the Scientific Director of LFB (Laboratoire Franais du Fractionnement et des Biotechnologies, Les Ulis, France). Dr. Burnouf is an informal advisor of WHO on quality and safety of blood products and access to safe plasma products in low- and middle-income countries. Recently he chaired the drafting group of WHO Guidance on increasing supplies of plasma-derived medicinal products in low- and middle-income countries through fractionation of domestic plasma".Thierry has published over 280 articles and book chapters related to plasma fractionation and blood

---

Daniel Candotti

Phd in virology, university paris 6, france. post-doctoral researcher for the anrs. research scientist program leader, r & d department of the nhsbt uk, & visiting researcher in the department of haematology, university of cambridge. senior research scientist in the department of blood transmitted agents, national reference center for transfusion infectious risks, national institute of blood transfusion, paris, france. currently, senior research scientist in the department of virology, henri mondor hospital ap-hp and university of paris-est, inserm u955, imrb, créteil, france. co-chairman of the virology subgroup of isbt ttid working party. research interest: persistent bloodborn viral infections, occult hbv infection, molecular epidemiology, blood safety.

Luciana Carlos

No bio provided

Simon Carter-Graham

Has been a nurse for 36 years in ed and then acute medicine. Worked at NHSBT for 20 years in various roles including area lead nurse and tissue donor co-ordinator. Has worked as clinical incident specialist in shot for 4 years.

Stuart Chesneau

No bio provided

: stuart-chesneau-16a2364

---

Sara Chiaretti

Senior Research Assistant, Australian Red Cross Lifeblood

Dr. Sara Chiaretti (BSC, MSC, PhD) is currently employed as a Senior Research Assistant acting research fellow in the clinical services and research department at Australian Red Cross Lifeblood.

Dr. Chiaretti’s work mainly focuses on reducing the risk of transfusion-related acute lung injury (trali) investigating the involvement of both antibodies and biological response modifiers (brms) in the different pathways of trali and testing potential preventive and therapeutic treatments.

Overall, dr chiaretti has published 11 manuscripts and 4 published abstracts. these publications have been cited 241 times resulting in a h-index of 8 and i10-index of 8. Over the years, she has trained and supervised several students, contributing to train the next generation of scientists.

Fenny Chong

My name is Fenny Chong. I am currently working on the blood safety at the Australian Red Cross Lifeblood in Brisbane, Australia. My role involves understanding the mechanisms underpin transfusion-related immune modulation to reduce the risk of blood transfusion and understanding erythropoiesis in rare blood group individuals to meet their transfusion requirements.

Previously worked at the University of Queensland, Brisbane, Australia on large scale embryonic stem cell culture for clinical use. I also worked at curtin university of technology in Perth, Australia for six years to screen potential drug treatments for allergic rhinitis.

Juan Manuel Cisneros Carrasco

No bio provided

---

Laura Cooling

Dr. Cooling received a BS Microbiology, MS Pathology and MD from the University of Iowa, followed by residency training in clinical pathology and transfusion medicine/blood banking at the University of Iowa Hospitals, USA. During her residency and training, she did extensive research in the area of platelet and red cells glycosphingolipids, including studies in parvovirus B19 and shiga toxin-related disorders. She is currently a Professor of Clinical Pathology at the University of Michigan, serving as Associate Medical Director of Transfusion Medicine, Director, Immunohematology Reference Laboratory and Director, Cellular Therapy Laboratory. She has been active in ASFA, ICII and AABB for many years, serving on multiple committees including Chair of the AABB Education Committee, AABB Annual Meeting Committee, ASFA Clinical Applications Committee and ASFA HPC Committee.

---

Janet Cox-Singh

No bio provided

Thane Moze Darumalinggam

Professional in Transfusion Medicine field, currently serving as Transfusion MedicineSpecialist in National Blood Centre, Kuala Lumpur. Over 12 years of experience intransfusion service and blood banking aspects. Presented many oral and poster presentationboth locally and internationally including ISBT. Contributed to several publications associated to blood donors.Also involved in active counselling and staff management pertaining to both professional and personal issues.Other key areas of interest includes blood procurement, understanding psychology of donors with donor care,medico-legal aspect, quality management system and patient blood management. Involved in giving lecturesfor students associated to transfusion service and post basic courses of Social Sciences. Fields handled under social sciences are motivation and team work. Effective communication and self-development.

---

Jennifer Davies

Dr jennifer davies is a transfusion laboratory manager at the royal devon and exeter nhs foundation trust and the northern devon healthcare nhs trust. she is a member of the serious hazards of transfusion steering group and the working expert group for information technology.

April Davis

April completed her phd at the university of sydney through the westmead institute for medical research in the areas of infectious disease, proteomics and molecular biology by examining the cellular transport of herpes simplex virus type 1. april now works as a research fellow at part of the product development research team at australian red cross lifeblood. her research explores the removal of hla class i from platelets and examines how frequent donation affects platelet donor health."

Thijs De Vos

Thijs de Vos is a medical doctor and currently working as a researcher in collaboration between the Leiden University Medical Center and Sanquin Research. His research project focusses on fetal and neonatal alloimmune thrombocytopenia.

Alana Delaforce

Alana is a registered nurse in the final stages of completing a phd that examines the barriers to implementing patient blood management guidelines. clinically, she has spent time working as a theatre nurse, specialising in the scrub/scout role. she moved into quality and safety in order to improve patient blood management practices. alana has recieved awards and competitive research funding for her work. locally, she has transformed transfusion practice and implemented a preoperative anaemia and iron deficiency pathway which now successfuly identifies patients who require optimisation prior to surgery.

Liling Delila

Liling delila got her bachelor degree (bs) from the state university of malang, indonesia. after her bs, she was recruited, as a fellowship awardee, to join taipei medical University (tmu) to accomplish her master degree in science at the graduate institute of biomedical materials and tissue engineering, college of biomedical engineering, Tmu, Taipei, Taiwan.

She is now doing her dual PhD program between gibmte-tmu and the University of Lille, France. Ms. Delila is currently in third first year of phd thesis since September 2019. The focus of her work is on the study of the possible application of platelet derived extracellular vesicles as neuroprotective biotherapy of neurodegenerative disorders.

Dana Devine

Dana Devine is currently the Chief Scientist at Canadian Blood Services. She is also the Director of the Centre for Blood Research and Professor of Pathology and Laboratory Medicine at the University of British Columbia. She was formerly the Chief Medical and Scientific Officer at Canadian Blood Services. In service to the transfusion community, Dr. Devine is a member of numerous advisory committees and boards including the American Red Cross, Vitalant Research Institute, Bloodworks Northwest, the New York Blood Center, the National Health Service Blood Transplant (UK) and the Australian Red Cross Blood Service. She served a nine year term as the Editor-in-Chief of the blood transfusion journal Vox Sanguinis. She is president of the AABB board of directors. Dr. Devine completed her research training at Duke University in North Carolina where she obtained the Ph.D. degree. She has a longstanding research career in blood products, transfusion medicine, platelet biology, complement biochemistry, and coagulation. Her research is funded by the Burroughs Wellcome Fund, Canadian Blood Services, Canadian Institutes of Health Research (CIHR) and the National Science and Engineering Research Council (NSERC). She is a fellow of the Canadian Academy of Health Sciences.

---

Maria Didriksen

I have a master's degree in Science of Public Health from University of Copenhagen, Denmark. Since 2016 I have been working as a research at the department of Clinical immunology, Copenhagen University Hospital, Rigshospitalet, where I am a part of the Dansich Blood Donor Study. Currently, I am finishing my ph.d. thesis. I mainly do epidemiological research that revovles around donor health. My research focuses mainly on neuropsychiatric disorders, particularly with a focus on sleep, restless legs syndrome, and depression causes and consequences hereof.

---

Saliou Diop

Saliou Diop is a Professor on Hematology and Blood Transfusion in Cheikh Anta Diop University (Dakar, Senegal) and Director of the national blood transfusion services in Senegal. He laso have great experience on hemophilia and inherited bleeding disorders as he's actually member of the World Federation of Hemophilia (WFH) Board of Directors and serve as Africa Regional adviser for WFH.

---

Marie-Pier Domingue

Marie-Pier Domingue is a Master student in Statistics at the University of Sherbrooke in Québec Canada

---

Kerry Dowling

No bio provided

Abigail Edwards

In 2019, Abigail graduated from the University of Queensland with a Bachelor of Science (honours) in the field of Psychology. Her honours research assessed unique question-based interventions for blood donor recruitment and retention, as well as the underlying emotional motivations. in 2021, Abigail began her phd at the University of Queensland under the helping the medical matchmakers: sustaining and understanding living donors research program.

Abigail’s current program of research assesses the impact of identifying as a blood donor on future intentions to donate blood. Her research falls within applied social psychology, a field which focuses on implementing social psychology theory to enact real world change.

---

Lise Estcourt

No bio provided

Peter Flanagan

Peter Flanagan has worked for New Zealand Blood Service for over 20 years and has played a key role in the establishment of a national blood service. He has a particular focus on blood safety and quality systems. He is currently the Chair of the ISBT Standing Committee on Ethics. He has been the President of the Australian and New Zealand Society of Blood Transfusion and of the International Society of Blood Transfusion. He is a member of the WHO Expert Panel for transfusion medicine.

---

Brigitte Flesch

From 1993 to 2009 senior scientist at the institute of transfusion medicine, university hospital schleswig-holstein, kiel, germany. focus: granulocyte and platelet serologs, fc gamma receptor mediated phagocytosis. since 2010 senior scientist and laboratory director immunogenetic / hla at the drk blutspendedienst west, bad kreuznach and hagen, germany. focus: hla diagnostics, rbc, granulocyte and platelet molecular genetics.

Yoke-Lin Fung

Lin FUNG is the Associate Professor in Medical Laboratory Science at the University of the Sunshine Coast (USC) where she lectures in blood banking and transfusion science, and haematology. She is the leader of the OptiBlood research team at USC, where research projects are focussed on optimising the patients own blood resource and the effective use of blood products. Some of her key areas of interest are neutrophil immunobiology and transfusion-related acute lung injury (TRALI) blood donors and donation practices in the Asia Pacific blood management and blood use in older adults blood management and use in cardiac surgery, major abdominal surgery and orthopaedic surgery Many of these projects are conducted by health professionals completing part-time MSc of PhD studies to address question/problems relevant to their work. These are only possible through close collaboration with local and international clinical colleagues.

---

Richard Gammon

Dr. gammon holds board certifications in blood banking and transfusion medicine as well as clinical pathology. he is a medical director for oneblood and transfusion medicine specialists. dr. gammon is an assistant professor of pathology for the university of central florida college as well as an assistant professor collaborative faculty with department of pathology and cell biology, university of south florida. he is chair of the aabb’s blood banks and transfusion service standards program unit and chair of the transfusion safety/patient blood management subsection. dr. gammon is co-chair of the technical scientific committee and a member of the education committee of the south central association of blood banks.

Cedric Ghevaert

Prof Ghevaert holds the Chair of Transfusion Medicine at the University of Cambridge and is a Consultant Haematologist for the NHS Blood and Transplant. His academic research group is based in the Wellcome-MRC Cambridge Stem Cell Institute in Cambridge, UK. He obtained his MD in 1998 from the University Libre de Bruxelles. After qualifying as a Consultant Haematologist, he did his PhD in Cambridge to develop recombinant antibodies for the treatment of fetomaternal alloimmune thrombocytopenia which culminated in a first-in-man study. Upon obtaining his PhD, Dr Ghevaert obtained a personal fellowship from the British Heart Foundation to work on megakaryopoiesis in the context of myeloproliferative diseases at the university of Birmingham. He was appointed as a Principal Investigator at the University of Cambridge in 2010. His current group focuses its work on the production of blood cells from pluripotent stem cells with the declared aim to produce novel cellular therapies for transfusion to patients. His approach combines the manipulation of key transcriptional regulators to efficiently forward programme stem cells into mature blood cells and 3D bioengineered scaffolds to recreate the bone marrow niche and increase the production efficiency and purity of the manufactured blood cells. His expertise lies at the hinge of basic bench-based science and translational studies."

---

Mindy Goldman

Dr. Goldman is a clinical hematologist with a fellowship in Transfusion Medicine. She has been active in many facets of transfusion medicine in Canada, including optimization of the donor screening process to ensure donor and recipient safety. She has contributed to assessment and implementation of blood donor criteria and policy changes. She is currently the Medical Director of Donor and Clinical Services at Canadian Blood Services.

---

Cecilia Gonzalez-Santesteban

Post-doctoral investigator in the reference laboratory of immunohematology in the banc de sang i teixits

Peter Gowland

Peter Gowland studied molecular biology at the institute for experimental cancer research (isrec) in epalinges obtaining his phd in 1990 from the University of Lausanne. from 1990 to 1997 he worked in hiv clinical laboratory research at the department of infectious diseases, Zürich University Hospital. from 1997 to 2000 he gained experience in medical microbiology with emphasis in molecular virology at the institute for infectious diseases form the Universities of Basel and Berne.

From 2000 he has worked at the interregional blood transfusion src (irb) in Berne as a senior research scientist where he is primarily responsible for research and development projects in blood-borne infectious diseases.

Laura Grech

No bio provided

Shane Grimsley

Working at the International Blood Group Reference Laboratory, NHSBT since 2009, as laboratory manager from 2015 and Senior Clinical Scientist since 2020, I have had the pleasure to help identify new blood group systems, new antigens and novel alleles. As well as helping lead a team of skilled and passionate scientists to resolve the worlds most complex immunohaematology cases, I have been able to contribute to ground-breaking projects that have improved the standards of care for patients.

---

Morgan Gueuning

From 2016 to 2019 i carried out my phd thesis in molecular ecology and evolution at the university of neuchatel (switzerland). after a postdoc on the same subject i started working at the zurich blood transfusion service as a scientific collaborator in the research and development department. my research at the blood transfusion service mainly gravitates around uncovering the genetics of blood group genes.

Narges Hadjesfandiari

Narges is a research associate in Canadian Blood Services. She also holds an adjunct professor position with department of pathology at the University of British Columbia (ubc), where she teaches histochemistry. she got her doctorate in pharmacy in iran and worked in a provincial health network for three years.

She then moved to Canada in 2010 to pursue her Phd in chemistry at UBC. Her thesis focused on the development of biocompatible and antimicrobial coatings for platelet storage bags. since joining Dr. Devine’s lab in 2018, she has mainly worked on projects inspired by the challenges or questions of blood banks besides research on understanding the donor characteristics affecting rbc quality. when she is not at work, she enjoys reading novels and playing with his son.

Richard Haggas

Richard Haggas has been working in the field of blood transfusion for over 35 years, initially in the Blood Service in Leeds and then in a hospital laboratory environment. He was the Chief Biomedical Scientist and Quality Manager in Blood Transfusion at Leeds Teaching Hospitals NHS Trust for over 15 years and is currently the Director at UK NEQAS Blood Transfusion Laboratory Practice. Richard is a member of the Transfusion Task Force of the British Society for Haematology and has been on the writing groups for a number of BSH guidelines He is currently on the organising committee for the BGS Transfusion conferences and a Trustee of the BGS Transfusion charity. Richard is currently the Honorary Treasurer of the British Blood Transfusion Society.

Akira Hayakawa

Dr. akira hayakawa has been studying the transcriptional regulation of human abo blood group genes and the molecular basis of abo variants, engaged in elucidation of the molecular basis of a/b blood group antigen reduction on red blood cells of patients with myeloid malignancies, has indicated that mutations of transcription factors runx1 and gata2 could play a role in these antigen reductions of patients with myelodysplastic syndrome using targeted sequencing panel and in vitro experiments, received young scientist award from japanese society for dna polymorphism research for those achievements, and has gained several academic grants additionally.

Nancy Heddle

Professor Emeritus in the Department of Medicine, McMaster University

Nancy is currently a Professor Emeritus in the Department of Medicine at McMaster University and the Research Director at the McMaster Centre for Transfusion Research. She has published over 225 scientific papers and given more than 260 presentations nationally and internationally. Nancy trained as a Medical Laboratory Technologist.

She completed a Masters degree in Health Research Methodology at McMaster University in 1992 and set up a clinical research program in Transfusion Medicine at McMaster University in 2001. Her research has utilized both qualitative and quantitative methodologies with a focus on evidence-based and safe transfusion practices. Throughout her career she has been an educator, a researcher and a mentor, teaching transfusion science and research methodology to over 250 fellows, residents, graduate students and medical laboratory technologists. A teaching award in her name was created by the Division of Hematology at McMaster University and is given annually to a faculty member who demonstrates excellence in teaching.

Nancy served as an Associate Editor for the journal Transfusion from 2004 to 2018 and initiated the Clinical Research Focus section for the journal as a resource to understand clinical research methodology.  She has received 18 national and international awards including the International Woman in Transfusion Award (AABB, BBTS and ISBT), the Emily Cooley Award from the AABB and a Lifetime Achievement Award from Canadian Blood Services.

---

Christine Henny

2016 - today    Group Leader, R&D Blood Group Diagnostics and Swiss National reference laboratory for Immunohematology Interregional Blood Transfusion SRC, Bern, Switzerland 

2013-2016     Senior Scientist,R&D Blood Group Diagnostics and Swiss National reference laboratory for Immunohematology Interregional Blood Transfusion SRC, Bern, Switzerland 

2011-2013    Postdoctoral Scientist, R&D Blood Group Diagnostics and Swiss National reference laboratory for Immunohematology Interregional Blood Transfusion SRC, Bern, Switzerland

---

Elisabeth Huis In 'T Veld

Through the faint project, elisabeth hopes to uncover more of how vvr can me measured and predicted in an early stage, using infrared thermal imaging and regular imaging techniques. she currently works as an assistant professor at the cognitive science and artificial intelligence department at tilburg university, and is pi donor cognition at the donor medicine research department, sanquin. together with judita rudokaité and co-founder cindy van goor, ainar (artificial intelligence for needle anxiety reduction; https://www.ainar.io) was founded, with partners sanquin and tilburg university. ainar is a serious game, that through neuroscientific and ai techniques can help people conquer needle fear and fainting

Sakara Hutspardol

I am a hematopathologist with a training background and work experience in pediatric hematology-oncology-stem cell transplant and hematopathology.

Kazumi Isa

Kazumi isa mt, is the chief of central blood institute at japanese red cross blood service headquarter. her main area of interest is polymorphism of blood group genes and its corresponding phenotypes, since 2009. she is the co-author of vox sanguinis best paper 2014 “deletion of the runx1 binding site in the erythroid cell-specific regulatory element of the abo gene in two individuals with the am phenotype”."

Jin-Sung Jang

2000~2006: Chonnam national university medical school, Gwangju, Korea

2007~2010: Boeun public health center, Boeun, Korea

2011~2022: Korean Red Cross Blood Services, Wonju, Korea

---

Mart Janssen

Mart Janssen, studied Mechanical Engineering at the Technical University Eindhoven after which he worked as a Risk Reliability engineer and Risk Management Consultant for eight years. In 2002 he switched to the University Medical Center Utrecht doing research in the field of Medical Technology Assessment. Since 2004 he has been working on blood transfusion related risk- and technology assessment studies for Sanquin, where in 2012 he became head of the Transfusion Technology Assessment group. 

---

Yanli Ji

Yanli Ji got the PhD degree in 2008 from Sun Yat-Sen University in China and then worked in the Institute of clinical blood transfusion in Guangzhou Blood Center to date. She focus on the research of RBC blood group genotyping and its application in the Chinese population. In 2018, she became of a member of ISBT working party of Red Cell Immunogenetics and Blood Group Terminology.

Aikaj Jindal

No bio provided

Wooi Seong Kam

Wooi Seong is the Assistant Group Director (Blood Supply) of the Blood Services Group at Health Sciences Authority (HSA), Singapore. He oversees the Blood Resources Division and Blood Supply Management Division, which are responsible for the collection, processing, testing and distribution of blood products to all hospitals in Singapore. The HSAs Blood Services Group runs the National Blood Program. Its mission is to secure the nation's blood supply by ensuring a safe and adequate blood supply.

---

Hiromi Kamada

"Since 1998, she has been a researcher at the japan red association in tokyo, japan. she is engaged in testing and research related to trali."

Rick Kapur

No bio provided

---

Jan Karregat

I am third year phd candidate who works at the dutch blood bank, sanquin. i have a background in biomedical science and i'm currently finishing a masters in epidimiology. for my phd trajectory i’m working on a project aimed at iron supplementation as a blood bank policy.

---

Christopher Kim

Christopher graduated from lafayette college with a double major in chemistry and mathematics. he has been working at columbia university irvine medical center for two years where he has led several projects relating to the lipid biochemistry of red blood cells (rbcs0 and the effects on rbc quality and transfusion outcomes. he will be continuing his education at johns hopkins where he will purse a doctorate degree in biochemistry, cellular, and molecular biology.

Thomas Klei

With his research, Thomas Klei focusses on red blood cell and platelet turnover in health and disease. Currently he is managing a research group that strives to improve quality of existing- and develop novel blood products and is directing implementation through clinical evaluation.

---

Pawinee Kupatawintu

Pawinee Kupatawintu obtained her bachelors degree in medical technologist from Chulalongkorn University and masters degree in medical Technologist from the Mahidol University. She has been working at National Blood Center since 1989. She had experiences in apheresis and red cell serology. She has been involved great skill in platelet antibody, HLA, bone marrow cryopreservation and unrelated stem cell donor registry fields for 16 years. She had been promoted to be assistant director of National Blood Centre, Thai Red Cross Society from 2016 to 2017 and currently being deputy director since 2018.

---

So-Yong Kwon

From July 2019 ro present, the Director of the Blood Safety Bureau at the Headquarters of the Korean Red Cross Blood Services

---

Cheuk Kwong Lee

Dr Lee is currently the Chief Executive and Medical Director of the Hong Kong Red Cross Blood Transfusion Service. He received his undergraduate and medical training at the University of Hong Kong and became specialist in Haematology and Haematological oncology at the Queen Mary Hospital, the University of Hong Kong, Hong Kong. After 8 years of clinical work, he moved to Hong Kong Red Cross Blood Transfusion Service where he became the head of Blood Collection and Donor Recruitment Department. Apart from his role in securing safe and adequate blood supply to patients in Hong Kong, Dr Lee is also the head of Hong Kong Bone Marrow Donor Registry which provide unrelated haematopoietic stem cells to patients undergoing transplantation. Dr Lee has developed interest at transfusion microbiology and donor health and medicine. He has made extensive contribution in understanding and implementing preventive measure in minimizing transfusion transmitted bacterial sepsis. Besides, as healthy and committed donors are success to the blood service, Dr Lee has been actively involved in studies to understand and minimize donation related vasovagal reaction and donors haemoglobin and iron. Recently, he and his team are actively working to increase the awareness and knowledge of the territory on Blood Supply, Blood Transfusion and Patient Blood Management.

---

Ursula La Rocca

Ursula la rocca, MD, PhD, hematologist with research interests in immunohematology and transfusion medicine, and hematopoietic stem cell transplantation
department of translational and precision medicine, sapienza University of Rome Italian national blood center, Italy
 

Johan Lagerberg

Johan Lagerberg is working at Sanquin Research since 2001. He is involved in research for new blood products and imporoving quality of current blood products.

Praiseldy Langi Sasongko

Syeldy (pronounced shel-dee) completed her bachelor's in in dallas, texas and moved to amsterdam, the netherlands to do her master's in global health. she landed an internship at sanquin, the dutch national blood bank and research division in 2017, where she was introduced to the world of blood banking and transfusion for the first time. since then, she's stayed at sanquin to complete her phd in organizational issues. she is the european representative of the isbt young professional council.

Luis Larrea

I am haematologist involved in transfusion medicine for more than 20 years, i work in valencian transfusion center, i am in charge of the processing department. also i am the president of the spanish transfusion society

Linda Larsson

Linda Larsson is a researcher from Karolinska Institutet, Stockholm, Sweden, focusing predominantly on red blood cell components. She has spent the past twelve years as the technical manager of blood component processing at the blood establishment of Karolinska University Hospital. last summer, she joined the edqm to assist in transfusion related projects; the blood supply contingency and emergency preparedness plan being one of her main focuses. 

Among her external missions, Linda is co-chair of the european hematology association scientific working group on transfusion, member of the european blood alliance working group on non-dehp transition, and member of chapter group 4, 5 and 6 for the edqm blood guide.

Alvina Lau

Dr. Alvina Lau Voon Na (mbbs, imu) is a medical officer with seven years of blood transfusion service experience at the national blood centre, kuala lumpur.

She served on the donor education committee for four years, raising awareness about blood donation and was subsequently appointed the head of donor registration and records unit for two years. She was also the principal editor of a five-year project with various transfusion experts to create a handbook on clinical use of blood. Currently,  she is leading and developing a clinical research unit in her organization. Her primary areas of focus are blood procurement, blood donors, research and data analysis and her goal is to continue advocating and conducting research in order to fill knowledge gaps to eventually improve the service.

Nhi Le

I am currently a 2nd-year master's student, from Taipei Medical University. Previously, I have researched bone materials and currently, my research area is on proteomics. With the dedicated help of prof. han, an expert in this field. I have been gradually completing my research. The purpose of this study is to better understand the proteomes of biological materials. this is an essential but important step to complete the research as well as verify the applicability of these materials.

Shui Shan Lee

Dr Lee is a clinician and specialist in internal medicine, immunopathology and public health. He joined The Chinese University of Hong Kong in 2005 and was awarded Daniel Yu Professorship in 2018. His is currently Research Professor and Deputy Director of the Universitys Stanley Ho Centre for Emerging Infectious Diseases. Between 1991 and 2005, Dr Lee headed the Hong Kong Governments AIDS programme, during which he directed the territorys HIV prevention, control and treatment services. He is the Founding President of Hong Kong Society for HIV Medicine, and has been chairman of Scientific Committee on AIDS and STI of the Governments Centre for Health Protection since 2016. He is an Associate Editor of International Journal of Infection Diseases, and Addiction. Dr Lee has, on various occasions, served as consultant to national and international organisations in the assessment of HIV situations, programme evaluations, and advise on harm reduction development. His major areas of research interest include biomedical approach to HIV prevention, infectious disease epidemiology, emerging infectious diseases. Dr Lee has authored over 250 peer-reviewed articles, 40 book chapters, and is the editor of the HIV Manual in Hong Kong.

---

Gerda Leitner

Medical career history 

• 1984-1988: Leader of the blood bank Kaiser Franz Josef Hospital/Vienna
• 1995 - 2007: Substitute of the head of the Department General Hospital / Vienna
• 2007 - 2010: Head of Department General Hospital / Vienna
• 2010-2017: Substitute of the leader of the Clinic for blood group serology and Transfusion Medicine General Hospital / Vienna
• 2012 -09/ 2021: Head of the production General Hospital / Vienna
• 2017- 09/2021: Interim head of Department General Hospital / Vienna
• 01/10/2021: retirement    
• 01/11/2021- currently: Project management / edv-implementation - ubt    general hospital, ubt/ vienna and project management: matched unrelated stem cell donor program-general hospital, ubt/vienna

Carol Lim

Dr. Carol KK Lim is a Maternal Fetal Medicine Consultant serving in a major public hospital in Malaysia. Her interest includes community obstetrics and she believes health system improvement is key to better maternal and neonatal health. Beside obstetric venous thromboembolism, maternal anemia is the other major area of interest of hers. For the same reason, she has been a vocal advocate and champion for Patient Blood Management (PBM) in her hospital and in Malaysia, as PBM is the key to managing anemia.

---

Tang Yee Loong

Dr. Tang is a medical lecturer working in the Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM). He is also a consultant haematologist working in the Department of Diagnostic Lab Service and the head of the Blood Bank unit, hospital UKM. He actively participates in many academic activities and currently serves as the reviewer of medical specialist CPD points in the Malaysian Medical Council, webmaster, and committee in College of Pathologists, Academy Medicine of Malaysia as well as a life member of the Malaysian Society of Haematology. He has completed the visitor training program organised by the American Society of Haematology at the prestigious Emory University Hospital in the year 2018. His current research mainly focused on haematological disorders and transfusion medicine.

---

Genghis Lopez

Dr Genghis Lopez is a Senior Scientist at the Australian Red Cross Lifeblood in Brisbane, Australia. Currently, he is a part of the Transfusion Science Research team that investigates complex blood group molecular variants. Prior to this role, he worked at Lifebloods Platelet and Granulocyte Reference Laboratory and the Red Cell Reference Laboratory. He is a member of the Australian New Zealand Society of Blood Transfusion and the ISBT.

---

Enrico Lopriore

No bio provided

Jessie S. Luken

Jessie Luken (MD) works as consultant in Transfusion Medicine and Immunohaematology Diagnostics at Sanquin Diagnostic services in Amsterdam. She works at Sanquin for 12 years.

---

Joy John Mammen

Joy Mammen MBBS, MD, did his medical training at the Christian Medical College (CMC) Vellore, followed by a Fellowship in Pathology Informatics in the USA. He is working in CMC since 1999, and currently heads the Department of Transfusion Medicine and is also an Associate Director there. His areas of interest include lab haematology, information management, voluntary blood donors, policy, and public health aspects of Blood Transfusion Service. He is an expert advisor to the National and State Blood Transfusion Services in India. He is a consultant to WHO SEARO in the same domain. He also serves on the board of directors of ICCBBA, an organization responsible for the global standard for medical products of human origin (ISBT128).

---

Denese Marks

A/Prof Marks has led the Product Development research team since 2008. She holds an adjunct appointment with the School of Medicine at the University of Sydney. Denese received her PhD from the University of Technology, Sydney in 1995. She has held post-doctoral fellowships at the University of Vienna, the University of Melbourne and Great Ormond Street Hospital in London. A/Prof Marks current research focuses on improving blood processing technologies and component storage, including platelet cryopreservation, investigating donor attributes that may influence blood component quality, and clinical trials of new blood products. She has over 100 peer-reviewed publications, and is a section editor for the Vox Sanguinis journal. She has leadership roles as a scientific member of the Conventional Components Team in the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, the Chair of the ISBT Blood Compnents Working Party and as a member of the ISBT Board of Directors. She currently holds grants from NHRMC, ARC, ANZSBT and the MRFF.

---

Yuyun Maryuningsih

Yuyun Siti Maryuningsih, Team Leader for Blood and other Products of Human Origin, Technical Standard and Specifications Unit, Health Products Policy and Standards Department, WHO Headquarter Specialty: Medical Doctor with specialization in Transfusion Medicine and a doctorate in Biomedical Sciences Education and Academic Career : 2010: PhD- Biomedical Science, Indonesian University, Indonesia 1996: Master's degree - Virology, Adelaide University, Australia 1988: Medical degree - Padjadjaran University, Indonesia Work Experience: Oct 2018-Now, WHO headquarters 2015-2018, Blood Services Program Coordinator at the Directorate of Primary Health Services within the Ministry of Health of Indonesia 2011-2018, Coordinator of the Master Program on Biomedics Specialty in Transfusion Science at Indonesian University 2004-2015, Director of the Central Blood Transfusion Service at the Indonesian Red Cross Affilation and membership: 2015-2017, Chairperson of the Indonesian Association of Transfusion Medicine (PDTDI) 2016-2019, Regional Director of the International Society of Blood Transfusion (ISBT) for South East Asia Region. 2015, Committee Member of Partnership Training Network of APEC Blood Supply Chain Forum 2005-2020, Member of the International Society of Blood Transfusion (ISBT) 2017-2019, Chairman for Indonesian National Blood Services Committee

---

Hanke Matlung

Hanke Matlung, PhD, was recently appointed by Sanquin to build and continuate diagnostics and research related to iron metabolism and disorders at Sanquin Iron Expert Center. This will benefit patients with iron disorders in general and health of donors and patients receiving blood products in particular. Before focusing on the field of iron disorders, she has 10 years of fundamental research experience in the field of phagocyte effector functions within the Phagocyte Laboratory at Sanquin.

---

Eva Maria Matzhold

In 2007 I earned a Master’s Degree in Molecular Microbiology from the Karl-Franzens-Universität, University of Graz, Austria.

For the doctoral studies I enrolled in medical sciences. My doctoral thesis investigated the genetic variations of fucosyltransferases 1, 2 and 3 in styrian blood donors and was awarded with a Thesis Prize of the Medical University of Graz in 2011. Since 2008 I have been working as biologist at the department of blood group serology and transfusion medicine, specializing in immunohematology and blood group genetics. since 2016 I have been lecturing in blood group serology and molecular immunohematology at the Medical University of Graz and at the University of Applied Sciences (fh Joanneum), Graz.

Eunike (Nysa) Chrisnysa Mcgowan

Eunike (nysa) Mcgowan is a senior research assistant at the australian red cross lifeblood. She obtained her phd from the university of queensland. Her current Research focus is in Blood Group Genomics.

Romy Meier

Romy is currently a phd candidate under the supervision of rick kapur and masja de haas. her research interests include vaccine-induced thrombotic thrombocytopenia and heparin-induced thrombocytopenia. she obtained a bachelors degree in biomedical sciences from the vu university amsterdam and a masters degree in biomedical sciences from the university of amsterdam. her previous research was in the field of neurobiology

Ryan A Metcalf

Dr. Metcalf is Section Chief of Transfusion Medicine, Medical Director of the Transfusion Service, Associate Professor of Pathology, and Inpatient Chief Value Officer for the Department of Pathology at the University of Utah Health and ARUP Laboratories. He completed a residency in Anatomic and Clinical Pathology and a fellowship in Transfusion Medicine at Stanford University. Dr. Metcalf practices transfusion medicine and his specific interests include data-driven/informatics approaches to patient blood management, quality management, and innovation. His research interests include the use of machine learning to predict patient blood management outcomes, data visualization to identify root causes from complex clinical data, and data-driven approaches to improve our understanding of risks associated with blood transfusion. Dr. Metcalf is Chair-Elect of the AABB Clinical Transfusion Medicine Committee, a member of the AABB Patient Blood Management Standards Committee, and a member of the College of American Pathologists (CAP) Transfusion, Apheresis, and Cellular Therapy Committee.

---

Aline Mirrione Savin

No bio provided

---

Toru Miyazaki

Toru miyazaki is a director of research and development of central blood institute, japanese red cross.
his work focuses red blood cell immunology using flow cytemetry or luminex technologies.
he is also interested in the production of monoclonal antibodies against red cells,  hla or neutrophils, and the phagocytosis assay of irregular antibodies.

Mr. Camous Moslemi

Molecular biology PhD student at Sjælland University Hospital specialising in bioinformatics and working with blood type genetics

Rachel Moss

Transfusion Practitioner, Great Ormond Street Hospital, London

No bio provided

: @Rachmosshibb

---

Sandra Nance

Sandra nance has provided leadership to the aamerican rare donor program, american red cross histocompatibility and immunogenetics laboratories, the national reference laboratories for blood group serology, molecular testing, neutrophil and specialized testing. she engineered the nationalized american red cross sbb program, first described the use of peg for immunohematology and is well known for the use of the mma to predict the survival of incompatible red cells.. she retired from the american red cross and acts now as a volunteer and is emeritus adjunct assistant professor at the university of pennsylvania. she is active in isbt and the working parties for rare donors and immunohematology.

Helen New

No bio provided

Rachel Nigriello

Dr Rachel Nigriello is an st2 emergency medicine trainee currently working at the royal united hospital in bath.

She studied medicine at the University of Bristol before completing her foundation training at the royal hampshire county hospital in Winchester. She has completed a pgcert in medical education whilst working as a clinical teaching fellow at the great western hospital in swindon where she developed her interests in novel uses of simulation.

Idaleswati Nor Mohamed

Dr. Idaleswati Nor Mohamed is a haemovigilance specialist with a special interest in blood safety and quality regulation. She works at the National Blood Centre in Kuala Lumpur as a Transfusion Medicine Specialist and the chief of the National Surveillance and Assessment Department. Dr. Nor Mohamed is dedicated to blood safety and developing the best strategies for donors and recipients. Bringing forth an empathic and professional approach, dedicated to offering the best possible treatment to patients. A competent leader who collaborates well with colleagues in the medical field.

---

Sheila F. O'Brien

Dr sheila o’brien completed her phd at the university of western australia in 1996, after which she completed post-doctoral training at the university of alberta. she then joined canadian blood services where she is the associate director of epidemiology and surveillance. her areas of research include the epidemiology of blood transmissible infectious disease, risk modelling, blood donor behavior and evaluation of blood donor questionnaires. dr. o’brien is the vice-chair of the isbt transfusion transmitted infectious diseases working party. she is a member of the transfusion editorial board and a member and former chair of the aabb donor history task force.

Melca Maria Oliveira Barros

1998 graduated in medicine at the federal university of alagoas, brazil
2003 medical residency in hematology and hemotherapy at the federal university of são paulo
2008 phd in hematology and hemotherapy at the federal university of são paulo, Brazil
 current - coordinator of the immunohematology laboratory of the blood bank of the universidade federal de sao paulo, brazil

Nicoletta Orlando

Dr  orlando has a biotechnology phd. she is now attending her residency in clinical pathology at università cattolica del sacro cuore in rome. she is currently involved in clinical and research activities at the unicatt cord blood bank and cell processing laboratory under the direction of prof. l. teofili. she is author of several papers in peer-review journals

Shirley Owosu

No bio provided

---

Shirley Owusu-Ofori

Dr. Shirley Owusu-Ofori is a Transfusion Medicine Consultant with wide experience in Blood Bank Management and Clinical Transfusion Medicine practice in Africa. She is the Head of Transfusion Medicine Unit of the Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana and has since 2015, doubled up as the Head of the Central Zone Blood Centre, National Blood Service Ghana. A keen advocate and trainer in blood safety and safe transfusion practices with a special interest in improving survival outcomes in Maternal and Paediatric patients. Shirley received her medical training in Kumasi, Ghana; and is a Fellow of the Ghana College of Physicians Laboratory Medicine Division. She also holds a Diploma in Transfusion Medicine of the Royal College of Physicians Edinburgh. She has undertaken blood transfusion fellowships in the East Anglia Blood Centre, Cambridge UK and the South- East Scotland Blood Transfusion Service in Edinburgh, Scotland as part of her postgraduate training. An active researcher for the past 20 years, she has over 55 publications including three Cochrane systematic reviews under the Cystic Fibrosis and Genetic Disorders and the Infectious Diseases Groups. Shirley was Principal investigator (PI) in the BOTIA (Blood and Organ Transmissible Infectious Agents) consortium, which spanned over three years (2006 and 2009), systematically collecting donor-recipient pairs of blood samples; both pre and post transfusion. She has also participated in several studies which have made progress in the knowledge of virus epidemiology in Ghanaian blood donors: West Nile Virus, B19 virus, GB virus-C, HBV and HCV. Her work includes evaluating adverse events associated with transfusions including disease transmission of agents such as malaria and HIV. Dr Owusu-Ofori has led clinical trials evaluating intervention methods to prevent disease transmission including novel diagnostic approaches and photochemical blood treatment systems to inactivate pathogens and white blood cells in blood products. Her recent work as the PI of the AIMS study (African Investigation of the Mirasol System) has been the subject of a publication in The Lancet. (Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial. Lancet. 2016 Apr 23;387 (10029):1753-61) 

Ilaria Pati

Ilaria Pati is a biologist, PhD in genomics and proteomics, with a Master's Degree in Molecular Virology. She is the referent for epidemiological surveillance of blood donors at the Italian National Blood Centre at the Italian National Institute of Health.

Gopal Patidar

No bio provided

Rachel Petermann

Rachel Petermann is in charge of Platelet Immunology service at the Centre National de Référence en Hémobiologie Périnatale (CNRHP) in Saint-Antoine Hospital, ap-hp, Paris, France.

She has obtained her medical degree followed her specialization in hemobiology transfusion and an academic degree doctor in medical sciences (phd). She is member of international (isbt, isth) and national societies (sfts, sfvtt and geht). formally, she was the head of the platelet immunology department in the national institute of blood transfusion (ints), a labmed with national and international expertise in fetal and neonatal alloimmunization thrombocytopenia and in prenatal diagnosis, particularly in non invasive prenatal diagnosis.

David Peterson

David is a transfusion medicine scientist and educator. He is currently the manager of BloodSafe e-learning Australia, an e-learning program funded by all states and territories of Australia to improve clinical transfusion practice by doctors, nurses, midwives and other healthcare staff involved in the transfusion chain across Australia

---

Thierry Peyrard

Thierry peyrard, pharmd/phd, european specialist in laboratory medicine, is the director of the national reference department of immunohematology and rare blood at the french blood establishment (efs) in paris, france. he runs the national immunohematology reference laboratory and the national rare blood bank. he manages a research group at the national institute of health and medical research and university of paris cité, primarily aiming to characterize new blood group systems and antigens . dr. peyrard is a member of the french national academy of pharmacy. he authored/co-authored 82 peer-reviewed publications. he is the chair of the isbt working party on immunohematology and a member of the isbt working party on red cell immunogenetics and blood group terminology  on rare donors.

France Pirenne

No bio provided

Anthony Poles

No bio provided

Simonetta Pupella

Transfusion medicine specialist. md degree university of rome. specialty in hematology, specialty in immunohaematology. post-doc "diplôme universitaire en transfusion sanguine".university of strasbourg, france. . from january 2011 – present deputy director director of the italian national blood centre, director of medical affairs & blood inspection systems. longstanding professional experience in transfusion medicine, blood and cord blood banking, stem cell collection and blood donor care. full competence in all regulatory issues ruled by national and european legislation on blood, blood components. good competence in quality system management and auditing of quality system in health care services, tissue establishment and transplantation programmes.

Annie Qiu

Annie qiu is a staff associate ii in dr. hudson’s laboratory at columbia university irving medical center. her research interests focus on understanding the immune response to transfused red blood cells (rbcs) by investigating the underlying mechanisms of rbc-specific alloantibody production. in understanding how the immune response forms against rbc alloantigens, she hopes to discover new clinical therapies for transfusion reactions.

Franke Quee

I'm a researcher with a background in biomedical sciences and epidemiology. the main focus of my research is blood donor health and blood donor behaviour. recently i started a phd trajectory focussing on the blood donor as sentinel for emerging infections. currently the majority of the work focusses on sars-cov-2 antibody testing in blood donors.

---

Sandra Ramirez-Arcos

"Dr. sandra ramirez-arcos trained as a microbiologist in her native colombia and then conducted phd studies in biological sciences in spain. from 1998 to 2002, dr. ramirez did her post-doctoral training and worked as a research associate at the university of ottawa. since 2003, she has worked at canadian blood services where she currently holds a senior scientist position. dr. ramirez is also an adjunct professor at the university of ottawa. dr. ramirez has built a strong team with expertise on bloodborne bacteria. her research projects are focused on understanding bacterial growth dynamics during blood component storage. her laboratory oversees the development, validation and implementation of protocols and processes aimed at enhancing blood component safety."

Glenn Ramsey

Dr. ramsey is professor of pathology at feinberg school of medicine, northwestern university, chicago, illinois, and medical director of the northwestern memorial hospital transfusion service. his interests include clinical transfusion practices, immunohematology and the application of blood group molecular testing to patient care. he received his medical degree from case western reserve university and completed his pathology residency and blood bank fellowship at university of rochester and university of pittsburgh, respectively. he is directory of the blood banking fellowship at northwestern university.

Maaike Rijkers

Maaike rijkers obtrained her phd in platelet immunology at sanquin research, the netherlands in 2019. now she works as project manager r&d at gendx.

Melanie Robbins

Dr Melanie Munro (Robbins) graduated from Royal Holloway University of London in Molecular Cell Biology in 1995.

She started her professional career studying a dphil at the University of Oxford before joining smithkline beecham (later glaxosmithkline (gsk)) as a senior scientist in neuroscience. After 10 years at gsk dr munro took a 5-year career break before joining the biotech company, abcam, where her career moved into scientific project management as director of pipeline and project management. After 6 years dr munro moved to nhsbt and currently works as a translational research programme lead for the universal plasma programme in the component development laboratory alongside dr rebecca cardigan, who is the department head and a principal investigator.

Judita Rudokaite

Ph.D. Candidate, Tilburg University (Department of Cognitive Science and Artificial Intelligence) & Sanquin

Judita Rudokaite has MSC in Neuroscience and Cognitive Science at Utrecth University and another MSC in Cognitive Science and Artificial Intelligence at Tilburg University. Currently she is a PhD candidate at Tilburg University, Department of Cognitive Science and Artificial Intelligence, and Sanquin Research, National Blood Bank in the Netherlands.

Her PhD project faint aims to investigate the underlying neurophysiological mechanisms behind the vasovagal reactions and develop an app-game-based solution for people with needle fear.

: judita-rudokaite-437261105

Suneeti Sapatnekar

Dr. suneeti sapatnekar is a staff physician in the section of transfusion medicine at cleveland clinic, ohio, usa. her professional interests include clinical transfusion medicine, immunohematology, molecular typing and medical education.

Michael Schmidt

Prof in transfusion medicine and working at the german red cross since 2003. member of the isbt and the isbt working party ttid.

Torsten J Schulze

Physician/researcher, studied in Lübeck, Barcelona, grenoble and valparaiso.

Trained in transfusion medicine in lübeck and mannheim. head of research & development and non-erythrocyte immunohematology lab (neih) in the German Red Cross Blood Service Nstob in Springe

Mallika Sekhar

Mallika Sekhar is a consultant haematologist and honorary associate Professor of Haematology. She trained in India, UK and USA and works in London. Her special interests in haematology are myeloproliferative diseases and blood transfusion.

Deanna Self

I worked for grifols in the field of blood screening assay development for over 15 years.

Elisabeth Semple

Dr Semple recieved her PhD in cell biology from the University of Linkping, Sweden. After specializing in production and storage of blood components, especially leuko-reduction and production of platelet concentrates, she moved on to stem cells and now to monoclonal antibodies. She has held leadership positions in the hospital and not-for-profit settings, in academia and in industry for over 35 years. After almost 20 years in North America, working in both Canada and the USA, she has returned to Sweden and is now Director of the Quality Control (QC) department at BioInvent International in Lund.

---

John Semple

No bio provided

---

Geoff Simon

No bio provided

Clarissa Skorupski

Dr. clarissa skorupski is a second year internal medicine resident at the university of toronto. she completed her bachelor's of science in molecular biology and genetics, and doctor of medicine at mcmaster university. she has an interest in hematology and research that supports evidence-based patient blood management practices.

Martin Smid

Martin Smid (1958, Netherlands, MD Medicine, PhD and MBA) has more than 25 years experience in blood bank management, transfusion medicine and coagulation. He is managing director of Sanquin Consulting Services and the Academic Institute IDTM. He is chair of the ISBT WP GBS since 2018 and member from the start in 2010. After the position of the WP was settled the focus is to make challenges for availability and safety of the blood supply globally and develop solutions to improve the situation in limited resource countries visible for ISBT membership. Martins main responsibilities include international cooperation and knowledge sharing in international projects and the Management of Transfusion Medicine programme at the Graduate School of Medical Science of the University of Groningen. He has contributed to projects in over 20 countries globally and is involved in the WHO Global Blood Safety Network and AfSBT Educational Committee and also is an advisor of the Curacao blood bank. He has over 50 publications in transfusion, hemophilia and coagulation. 

---

Jill Storry

Jill Storry is Professor of Experimental Transfusion Medicine at the Division of Haematology Transfusion Medicine, Department of Laboratory Medicine, Lund University (LU), Sweden, and also responsible for the Immunohematology laboratories within the Department of Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Lund. Primary areas of interest are the study of human blood group systems, both from a clinical perspective in the provision of providing blood to alloimmunised patients and from the perspective of human polymorphism, and its role in health and disease. Her research focus is the investigation and characterisation of erythrocyte membrane glycoproteins carrying blood group polymorphisms, their function and interaction with pathogens, e.g. malarial parasites. Jill is a member of the Editorial Boards of Transfusion Medicine Reviews, Transfusion and Immunohematology, Section Editor for Vox Sanguinis and a peer reviewer for these and other scientific journals. She is a member of the ISBT Working Parties on Red Cell Immunogenetics and Red Cell Nomenclature, and Rare Donors.

---

Colton Strong

Colton is a 2nd year phd candidate studying biochemistry and molecular biology at the university of british columbia.

Manvi Talwar

I completed a three years residential training program in the department of transfusion medicine at postgraduate institute of medical education and research (pgimer), chandigarh, india on 31st december 2021.

Pgimer has been declared as an institute of national importance by the indian government. I am currently working as a Senior Resident at Medanta-the Medicity, Gurgaon ,India. As part of the curriculum I trained extensively in various areas of transfusion medicine and attended clinical rotations in paediatrics, obstetrics and gynaecology, immunopathology and microbiology which helped me understand the importance of coordination between transfusion and clinical services for maximizing patient safety and clinical outcomes.

Nicole Thornton

Nicole is Head of the International Blood Group Reference Laboratory (IBGRL), in Bristol, UK. Nicole is an acknowledged expert in blood groups, blood group genetics, antibody identification and rare blood provision and is particularly passionate about promoting the need for a combined serological and molecular approach to solving the most complex immunohaematology problems. Nicole is the Vice Chair of the ISBT Working Party on Immunohaematology, a member of the ISBT Working Party on Rare Donors and also the ISBT Working Party on Red Cell Immunogenetics and Blood Group Terminology.

Rachel Thorpe

Dr Rachel Thorpe is a health sociologist and research fellow at australian red cross lifeblood. her research focuses on the social context of donation and using social theories to understand blood donors and donation through qualitative and quantitative methods.

Pierre Tiberghien

M.d., ph.d., and clinical hematologist at the besançon university hospital, france until 2009, pierre tiberghien headed the bourgogne france-comté etablissement français du sang (efs) blood transfusion establishment before taking up the position of efs deputy ceo, head of medicine and research and qualified person from 2009 to 2017. he is currently senior advisor for european and international medical and scientific affairs at efs. professor of medicine at the université of franche-comté, pierre tiberghien teaches immunology and transfusion medicine. his main research focus is on immunotherapy as well as on safety and efficacy of blood products. pierre tiberghien is president of the european blood alliance since january 1rst, 2020.

Jarkko Toivonen

The author got his phd in compute science in year 2019 from the university of helsinki, finland. since then he has worked at the finnish red cross blood service, doing blood donor health related research.

---

Ashley Toye

No bio provided

Teguh Triyono

Dr Teguh Triyono graduated from Doctoral Program of Universitas Gadjah Mada Yogyakarta Indonesia. He has been worked as lecturer in Faculty of Medicine, Universitas Gadjah Mada, and the head of Dr Sardjito Hospital Transfusion Services for more than 15 years, with many publications. He recently active as the chairman of National Transfusion Committee, and a member of National Comittee of Patient Safety, as well as a member of the Advisory Group WHO on Blood Regulation-Availability-Safety.

---

Nelson Tsuno

1987: Graduated from the Faculty of Medicine, University of Sao Paulo (Brazil) 1995: Graduated from the Faculty of Medical Sciences, the University of Tokyo (Japan), and obtained the PhD 1996 - 2009: Assistant professor of the Department of Transfusion Medicine, the University of Tokyo 2010 - 2014: Lecturer and Vice-Director of the Department of Transfusion Medicine, the University of Tokyo 2015: Project Physician at Astrazeneca 2015 - 2017: Medical Director at Novartis Pharma Medical Headquarters 2017: Graduated in Master of Business Administration (MBA) from McGill University (MBA Japan course) 2017 - Present: Senior Director of the Laboratory Department, Japanese Red Cross Kanto-Koshinetsu Block Blood Center 2019 - Present: Visiting Associate Professor, Keio University, Center for Transfusion Medicine and Cell Therapy 2019 - Present: Deputy Director General, Japanese Red Cross Kanto-Koshinetsu Block Blood Center 2021: Associate Editor, ISBT Science Series 2022: Section Editor, Vox Sanguinis

---

Kathryn Tulley

"Kathryn is an advanced specialist biomedical scientist working in the red cell reference department at the international blood group reference laboratory, nhs blood and transplant (nhsbt), bristol, uk. kathryn has 20 years laboratory experience in complex red cell serology. her current role is to co-ordinate and implement the management of the nhsbt rare donor screening program and has a particular focus on developing and optimising the testing strategy to improve rare blood provision."

John-Paul Tung

Senior Research Fellow, Australian Red Cross LifeBlood

No bio provided

---

Esa Turkulaine

No bio provided

Marion Vermeulen

Marion is the Executive: Transfusion Medicine and Technical Services at the South African National Blood service (SANBS). Her current role consists of the development of the SANBS strategy with direct responsibility for the testing, processing, issuing, transportation and logistics of 1 million donations per annum. Marion has been actively involved in research during her career with regards to TTIs and has published over 50 manuscripts. More recently Marion is the principle investigator for the PROTECT COVID19 Convalescent plasma donor and anti-SARS-COV-2 seroprevalence studies. In addition to these SANBS commitments, Marion also provides mentorship to young investigators in clinical research through the international society for blood transfusion (ISBT).

---

Marieke Vinkenoog

Marieke vinkenoog is a phd student with a background in biology and statistics. in her phd research, she applies data science methodology to predict iron levels in blood donors, based on previous donations. eventually, this line of research will lead to personalized donation intervals for donors, thereby reducing deferral rates due to low iron levels.

Alexander Vlaar

Professor Intensive Care Medicine, Amsterdam UMC

Alexander Vlaar. PhD, MD, MBA is professor Intensive Care Medicine (H-index: 31, 4.570 citation, > 220 articles) and principal investigator in intensive care medicine.

The focus of his research is transfusion-related morbidity and mortality. His research lines consist, among others, of pre-clinical and clinical investigation in the field of antibody and non-antibody mediated transfusion related acute lung injury (TRALI) and transfusion associated circulatory overload (TACO).

He is the chair of the international TRALI re-definition working group and chair of the ESICM Transfusion Task Force.

: alexander-vlaar-13a6338

---

Merel L Wemelsfelder

I am a second year phd student at sanquin research, focusing on the optimization of the blood supply chain, by the use of both mathematical optimization and reinforcement learning.

Connie Westhoff

No bio provided

Narelle Whiting

Narelle is an Senior Scientist of with 38years experience in areas of immunohaematology and haematology. She recently gained her fellowship of aims (Australian Institute of Medical Scientists) and has particular interest in development of competency and training programs for scientific staff.

Kelly M Winter

Since completing her PhD in 2009, Kelly has worked on improving blood processing and component quality. her projects have included the effect of short-term temperature excursions on platelet quality, quality studies on underweight red cell units, understanding the effects of gamma-irradiation of red cell concentrates and investigating the in vitro quality of red blood cells following pathogen inactivation.

Kelly’s recent research includes work in the frozen blood program, comparing red cell additive solutions to resuspend deglycerolised red cells and enhance the deglycerolisation process to improve product quality.

Erica Wood

Head, Transfusion Research Unit, Monash University

Erica Wood is the immediate past president of ISBT, and a member of its working parties on clinical practice, haemovigilance, and transfusion-transmitted infectious diseases. From 2010-2014 she was ISBT regional director for the Western Pacific region.

Erica is head of the Transfusion Research Unit in the Department of Epidemiology and Preventive Medicine at Monash University in Melbourne, Australia. She is a consultant haematologist at Monash Health and holds an honorary appointment at the Peter MacCallum Cancer Centre. Erica is past president of the International Haemovigilance Network, past-president of the Australian and New Zealand Society of Blood Transfusion, and a member of the World Health Organization Expert Advisory Panel in Transfusion Medicine. Erica has served as Chief Examiner (Haematology) for the Royal College of Pathologists of Australasia and chair of the Joint Specialist Advisory Committee in Haematology.

She is a member of the Victorian Blood Matters program advisory committee and the expert group of its Serious Transfusion Incident Reporting (STIR) haemovigilance program. In 2013, Erica was awarded a Churchill Fellowship to support her practice and research in patient blood management and haemovigilance, and in 2022 she was awarded the International Haemovigilance Medal by IHN.

: @erica_m_wood

---

Han Qi (Wayne) Zhao

Wayne Zhao is a phd candidate in Dr. Dana Devine’s lab at the University of British Columbia. He began his PhD thesis on cold-stored platelets in 2017. He has since published 3 peer reviewed articles on the subject. Wayne’s PhD study on cold-stored platelets is supported by the canadian blood services graduate fellowship.

Jingcheng Zhao

PhD Candidate in Transfusion Epidemiology, Karolinska Institutet

Jingcheng Zhao is a physician and PhD candidate in transfusion epidemiology at Karolinska Institutet.

Xin Zheng

I have been working in Shenzhen Blood Center, engaged in blood screening and testing and scientific research, the research direction was virology molecular immunity. It has investigated the prevalence of occult hepatitis b virus in blood donors for 10 years.in 2011, the first molecular characterization of occult hepatitis b by genotype b and c was completed in China, and the mechanism of occult hepatitis b virus after hbv vaccination was completed in 2015.

At present, the main work was to study the long-term prognosis of occult hepatitis b virus infected persons, and to obtain important and valuable data.